Xtant Medical Holdings, Inc. (XTNT) earnings
XTNT earnings moved a median of -4.26% by the close. Quarterly and annual XTNT reports and results, each read against the price at its own news timestamp. Back to the XTNT overview →
30 measured XTNT earnings events.
Where these XTNT earnings landedvs 28 measured XTNT earnings reactions
| Middle 50% of XTNT earnings reactions | -8.16% to -0.19% |
|---|---|
| Median reaction (to close) | -4.26% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 XTNT earnings events with a measured close landed between -8.16% and -0.19%; 21% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Xtant Medical Holdings, For: Jun 30 | SEC filing · Form 10-Q | +2.70% | -13.51% | |
| Xtant Medical Reports Second Quarter 2026 Financial Results | Press release | +2.70% | -13.51% | |
| Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026 | Press release | — | +0.61% | |
| Form 10-Q Xtant Medical Holdings, For: Mar 31 | SEC filing · Form 10-Q | -0.04% | -4.86% | |
| Xtant Medical Reports First Quarter 2026 Financial Results | Press release | -0.04% | -4.86% | |
| Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 | Press release | — | -1.72% | |
| Form 10-K Xtant Medical Holdings, For: Dec 31 | SEC filing · Form 10-K | +3.84% | +3.47% | |
| Form 10-Q Xtant Medical Holdings, For: Sep 30 | SEC filing · Form 10-Q | +2.20% | -0.49% | |
| Xtant Medical Reports Third Quarter 2025 Financial Results | Press release | +2.20% | -0.49% | |
| Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025 | Press release | +5.69% | -8.17% | |
| Form 10-Q Xtant Medical Holdings, For: Jun 30 | SEC filing · Form 10-Q | -0.77% | — | |
| Xtant Medical Reports Second Quarter 2025 Financial Results | Press release | +1.19% | — | |
| Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025 | Press release | — | -0.25% | |
| Form 10-Q Xtant Medical Holdings, For: Mar 31 | SEC filing · Form 10-Q | -7.03% | +1.12% | |
| Xtant Medical Reports First Quarter 2025 Financial Results | Press release | -7.03% | +1.12% | |
| Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025 | Press release | -1.88% | +5.96% | |
| Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% | Press release | -0.02% | -3.66% | |
| Form 10-K Xtant Medical Holdings, For: Dec 31 | SEC filing · Form 10-K | -0.88% | +6.32% | |
| Form 10-Q Xtant Medical Holdings, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -8.16% | |
| Xtant Medical Reports Third Quarter 2024 Financial Results | Press release | +0.00% | -8.16% | |
| Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024 | Press release | — | +0.00% | |
| Form 10-Q Xtant Medical Holdings, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -6.81% | |
| Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% | Press release | +0.00% | -6.81% | |
| Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024 | Press release | +0.00% | -6.81% | |
| Form 10-Q Xtant Medical Holdings, For: Mar 31 | SEC filing · Form 10-Q | -0.01% | -16.07% | |
| Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance | Press release | -0.01% | -16.07% | |
| Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 | Press release | -0.31% | -6.86% | |
| Form 10-K Xtant Medical Holdings, For: Dec 31 | SEC filing · Form 10-K | -11.02% | -12.71% | |
| Form 10-Q Xtant Medical Holdings, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.71% | |
| Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023 | Press release | — | -2.50% |
Keep exploring
More XTNT: analyst actions → · SEC filings → · XTNT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SIENNA BIOPHARMACEUTICALS (SNNA) | 193 | 0.00% | 40% |
| Spero Therapeutics, Inc. (SPRO) | 193 | +0.01% | 54% |
| Apollo Medical Holdings, Inc. (AMEH) | 192 | +0.16% | 55% |
| Citius Pharmaceuticals, Inc. (CTXR) | 192 | -1.42% | 30% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.